Andrew (Andy) Simmons

Andrew (Andy) Simmons

Company: Clovis Oncology

Job title: Vice President - Translational Medicine


Innovations in peptide targeted radionuclide therapies to target fibroblast activation protein (FAP) in solid tumors 3:35 pm

Review data that provide a strong rationale for targeting FAP with radiopharmaceuticals Discuss nonclinical characterization and clinical development of the FAP targeted radiopharmaceutical FAP-2286Read more

day: Track A

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.